A Study of KZR-616 in Patients With SLE With and Without Lupus Nephritis
Public ClinicalTrials.gov record NCT03393013. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1b/2 Study of KZR-616 in Patients With Systemic Lupus Erythematosus With and Without Nephritis (MISSION)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This was a Phase 1b/2, multi-center study in which patients received KZR-616, administered as a subcutaneous (SC) injection weekly for 13 weeks (Phase 1b) or 24 weeks (Phase 2).
Study identification
- NCT ID
- NCT03393013
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 69 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 20, 2018 (Actual)
- Primary completion
- Aug 4, 2022 (Actual)
- Completion
- Aug 4, 2022 (Actual)
- Last update posted
- Nov 18, 2025
2018 – 2022
United States locations
- U.S. sites
- 17
- U.S. states
- 8
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Academic Medical Research Institute | Los Angeles | California | 990022 | — |
| Inland Rheumatology Clinical Trials, Inc. | Upland | California | 91786 | — |
| SouthCoast Research Center, Inc. | Miami | Florida | 33136 | — |
| Hope Clinical Trials, Inc. | Miami | Florida | 33165 | — |
| Omega Research Maitland | Orlando | Florida | 32808 | — |
| Arthritis Center, Inc | Palm Harbor | Florida | 34684 | — |
| Advent Health Medical Group | Tampa | Florida | 33614 | — |
| University of Iowa | Iowa City | Iowa | 52242 | — |
| Northwell Health | Great Neck | New York | 11021 | — |
| NYU Langone Orthopedic Center - Seligman Center for Advanced Therapeutics | New York | New York | 10016 | — |
| University of Rochester Medical Center | Rochester | New York | 14620 | — |
| The Ohio State University Wexner Medical Center | Columbus | Ohio | 43210 | — |
| SC Nephrology & Hypertension Center, Inc. | Orangeburg | South Carolina | 29118 | — |
| Ramesh C. Gupta, MD | Memphis | Tennessee | 38119 | — |
| MedResearch, Inc. | El Paso | Texas | 79902 | — |
| Accurate Clinical Research, Inc. | Houston | Texas | 77034 | — |
| Accurate Clinical Management, LLC | Houston | Texas | 77084 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03393013, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 18, 2025 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03393013 live on ClinicalTrials.gov.